Massage, Oncology, Pain, Anxiety, Feasibility
Part of paid clinical trials in Lexington, Kentucky.
- Sponsor
- Jill Cole
- Study ID
- NCT07502157
- Status
- Recruiting
Conditions
- Gynecologic Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Massage Therapy — PROCEDUREGynecologic patient receiving an infusion will receive massage therapy for 15-20 minutes. The patient will have a choice of a hand, foot, or posterior neck and shoulder Swedish massage.
- Attention Control — PROCEDUREMassage therapist sits with gynecologic patient receiving an infusion asking questions for no more than 15 minutes.
Study Details
The goal of this clinical trial is to determine the feasibility of studying massage therapy in patients with gynecologic cancers while receiving infusion treatments. The central hypothesis is that it is feasible to implement a massage intervention study in an infusion center at an academic hospital, and measure pain and anxiety in patients with gynecological cancer. The main questions it aims to answer are: Can investigators evaluate feasibility to conduct a study from a design standpoint? Can investigators assess the use of randomization, blinding of assessors, potential to control the study with an attention group, and recruitment/retention processes? Can investigators successfully collect outcome measures of pain and anxiety, pre/post intervention? Researchers will investigate degree of resources needed, such as massage therapists, assessors, and timing of delivery intervention. Assess positive/negative effects on target population determining massage modality and anatomical location. Researchers will compare massage therapy to an attention control group, to see if massage therapy works to treat pain and anxiety in patients with cancer. Establish variability in outcome measures. Participants will: Be randomized and receive either massage therapy or attention control over the course of three consecutive infusion therapy treatments. Each infusion therapy treatment occurs every 2-4 weeks.
Key Dates
- First listed
- Mar 30, 2026
- Start date
- Aug 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Placebo Comparator: Attention Control, No Massage TherapyAttention Control, No Massage Therapy
- Experimental: Massage TherapyMassage Therapy
Primary Outcome Measure
Recruitment feasibility [ Time Frame: 6 months ]
Central Contacts
- Jill S Cole, MA, LMT, BCMTB859-323-7087
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kentucky | Lexington | Kentucky | 40506 | Jill S Cole, MA, LMT, BCTMB (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Lexington, KY
Related Studies
- Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial CancerRecruiting · Denise Fabian · Lexington, Kentucky
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- Mindfulness in Endometrial and Cervical CancerRecruiting · St. Louis University · St Louis, Missouri
- Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving ImmunotherapyRecruiting · Viome · Orlando, Florida